Vyne Therapeutics Inc (VYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2017 | 12-2016 | 12-2015 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 0 | 4,027 | 4,020 |
| Marketable Securities | 0 | 26,881 | 26,880 |
| Other current assets | 0 | 632 | 640 |
| TOTAL | $0 | $31,540 | $31,540 |
| Non-Current Assets | |||
| Investments And Advances | 0 | 0 | 10,420 |
| Other Non-Current Assets | 0 | 0 | 60 |
| TOTAL | $N/A | $N/A | $10,480 |
| Total Assets | $0 | $42,053 | $42,050 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 0 | 630 | 1,520 |
| Accrued Expenses | 0 | 130 | 580 |
| Other current liabilities | 0 | 0 | 1,790 |
| TOTAL | $0 | $3,903 | $3,900 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 60 | 50 |
| TOTAL | $N/A | $60 | $8,580 |
| Total Liabilities | $0 | $12,491 | $12,490 |
| Shareholders' Equity | |||
| Common Shares | 0 | 1 | 1 |
| Retained earnings | 0 | -30,115 | -30,110 |
| Other shareholders' equity | 0 | 59,586 | 58,979 |
| TOTAL | $0 | $29,562 | $29,560 |
| Total Liabilities And Equity | $0 | $42,053 | $42,050 |